RYTM logo

Rhythm Pharmaceuticals (RYTM) EBITDA

Annual EBITDA

-$170.22 M
+$4.02 M+2.31%

December 31, 2023

Summary

Performance

1-Year Change

+2.31%

3-Year Change

-27.69%

5-Year Change

-118.3%

15-Year Change

-428.82%

RYTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.83%
RYTM annual EBITDA is higher than 9.83% of companies in Healthcare sector

High & Low

All-time High

-$10.57 M

3-Year Low

-$174.25 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RYTM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 26, 2025
RYTM next annual earnings announcement is scheduled for Feb 26, 2025

OtherRYTMprofitabilitymetrics:

Annual Revenue

$77.43 M
RYTM annual revenue is $77.43 million

Annual Net Income

-$184.68 M
RYTM annual net profit is -$184.68 million

Annual EBIT

-$170.22 M
RYTM annual earnings before interest & taxes is -$170.22 million

Annual EPS

-$3.20
RYTM annual earnings per share is -$3.20

Quarterly EBITDA

-$38.36 M
-$11.57 M-43.19%

September 30, 2024

Summary

Performance

3-Month Change

-43.19%

1-Year Change

+71.78%

3-Year Change

+24.09%

5-Year Change

+24.09%

RYTM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.96%
RYTM quarterly EBITDA is higher than 11.96% of companies in Healthcare sector

High & Low

All-time High

-$6.33 M

3-Year Low

-$135.91 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RYTM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
RYTM next earnings announcement is scheduled for Feb 26, 2025

OtherRYTMprofitabilitymetrics:

Quarterly Revenue

$33.25 M
RYTM quarterly revenue is $33.25 million

Quarterly Net Income

-$43.64 M
RYTM quarterly net profit is -$43.64 million

Quarterly EBIT

-$38.74 M
RYTM quarterly earnings before interest & taxes is -$38.74 million

Quarterly EPS

-$0.73
RYTM quarterly earnings per share is -$0.73

TTM EBITDA

-$237.53 M
+$1.85 M+0.77%

September 30, 2024

Summary

Performance

3-Month Change

+0.77%

1-Year Change

+7.05%

3-Year Change

-40.86%

5-Year Change

-40.86%

RYTM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.2%
RYTM TTM EBITDA is higher than 6.2% of companies in Healthcare sector

High & Low

All-time High

-$6.34 M

3-Year Low

-$255.54 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RYTM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
RYTM next earnings announcement is scheduled for Feb 26, 2025

OtherRYTMprofitabilitymetrics:

TTM Revenue

$112.53 M
RYTM TTM revenue is $112.53 million

TTM Net Income

-$258.91 M
RYTM TTM net profit is -$258.91 million

TTM EBIT

-$239.13 M
RYTM TTM earnings before interest & taxes is -$239.13 million

TTM EPS

-$4.33
RYTM TTM earnings per share is -$4.33

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$170.22 M
RYTM annual EBITDA is -$170.22 million

Annual Net Income

-$184.68 M
RYTM annual net profit is -$184.68 million

Annual Interest Expense

$13.89 M
RYTM annual interest expense is $13.89 million

Annual Income Tax

$564.00 K
RYTM annual income tax is $564.00 thousand

Annual D&A

$1.76 M
RYTM annual depreciation & amortization is $1.76 million

RYTM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.3%+71.8%+7.0%
3 y3 years-27.7%+24.1%-40.9%
5 y5 years-118.3%+24.1%-40.9%

RYTM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-148.7%+2.3%-43.2%+71.8%-41.1%+7.0%
5 y5-year-148.7%+2.3%-43.2%+71.8%-79.4%+7.0%
alltimeall time-1510.0%+2.3%-505.5%+71.8%-3643.6%+7.0%

Rhythm Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$38.36 M(+43.2%)
-$237.53 M(-0.8%)
Jun 2024
-
-$26.79 M(-80.3%)
-$239.38 M(-6.3%)
Mar 2024
-
-$135.91 M(+272.7%)
-$255.54 M(+51.8%)
Dec 2023
-$170.22 M(-2.3%)
-$36.47 M(-9.3%)
-$168.29 M(-1.5%)
Sep 2023
-
-$40.20 M(-6.4%)
-$170.86 M(+1.1%)
Jun 2023
-
-$42.96 M(-11.7%)
-$168.93 M(-0.9%)
Mar 2023
-
-$48.66 M(+24.6%)
-$170.49 M(-2.2%)
Dec 2022
-$174.25 M(+154.5%)
-$39.04 M(+2.0%)
-$174.25 M(-6.2%)
Sep 2022
-
-$38.27 M(-14.0%)
-$185.74 M(-2.9%)
Jun 2022
-
-$44.52 M(-15.1%)
-$191.25 M(+2.4%)
Mar 2022
-
-$52.41 M(+3.7%)
-$186.85 M(+10.8%)
Dec 2021
-$68.45 M(-48.6%)
-$50.53 M(+15.4%)
-$168.63 M(+12.1%)
Sep 2021
-
-$43.79 M(+9.2%)
-$150.41 M(+6.9%)
Jun 2021
-
-$40.12 M(+17.3%)
-$140.74 M(+6.3%)
Mar 2021
-
-$34.20 M(+5.8%)
-$132.37 M(-0.7%)
Dec 2020
-$133.31 M
-$32.32 M(-5.3%)
-$133.31 M(-1.3%)
Sep 2020
-
-$34.11 M(+7.5%)
-$135.02 M(-2.0%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$31.75 M(-9.6%)
-$137.83 M(-8.1%)
Mar 2020
-
-$35.13 M(+3.2%)
-$150.02 M(+3.3%)
Dec 2019
-$145.17 M(+86.2%)
-$34.03 M(-7.8%)
-$145.17 M(+5.1%)
Sep 2019
-
-$36.92 M(-16.0%)
-$138.07 M(+14.8%)
Jun 2019
-
-$43.94 M(+45.1%)
-$120.29 M(+31.7%)
Mar 2019
-
-$30.27 M(+12.4%)
-$91.31 M(+17.1%)
Dec 2018
-$77.97 M(+142.2%)
-$26.94 M(+40.8%)
-$77.97 M(+25.8%)
Sep 2018
-
-$19.14 M(+27.9%)
-$61.96 M(+21.4%)
Jun 2018
-
-$14.96 M(-11.7%)
-$51.05 M(+19.3%)
Mar 2018
-
-$16.94 M(+55.1%)
-$42.79 M(+32.9%)
Dec 2017
-$32.19 M(+25.0%)
-$10.92 M(+32.7%)
-$32.19 M(+8.8%)
Sep 2017
-
-$8.23 M(+22.9%)
-$29.59 M(+6.8%)
Jun 2017
-
-$6.70 M(+5.8%)
-$27.70 M(+31.9%)
Mar 2017
-
-$6.33 M(-23.9%)
-$21.00 M(+43.2%)
Dec 2016
-$25.76 M(+143.6%)
-$8.32 M(+31.1%)
-$14.66 M(+131.1%)
Sep 2016
-
-$6.34 M
-$6.34 M
Dec 2015
-$10.57 M
-
-

FAQ

  • What is Rhythm Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals annual EBITDA year-on-year change?
  • What is Rhythm Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Rhythm Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Rhythm Pharmaceuticals?
  • What is Rhythm Pharmaceuticals TTM EBITDA year-on-year change?

What is Rhythm Pharmaceuticals annual EBITDA?

The current annual EBITDA of RYTM is -$170.22 M

What is the all time high annual EBITDA for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high annual EBITDA is -$10.57 M

What is Rhythm Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, RYTM annual EBITDA has changed by +$4.02 M (+2.31%)

What is Rhythm Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of RYTM is -$38.36 M

What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high quarterly EBITDA is -$6.33 M

What is Rhythm Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, RYTM quarterly EBITDA has changed by +$97.55 M (+71.78%)

What is Rhythm Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of RYTM is -$237.53 M

What is the all time high TTM EBITDA for Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals all-time high TTM EBITDA is -$6.34 M

What is Rhythm Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, RYTM TTM EBITDA has changed by +$18.02 M (+7.05%)